Françoise de Craecker
Directeur/Membre du Conseil chez X4 PHARMACEUTICALS, INC.
Fortune : 97 634 $ au 31/05/2024
Profil
Françoise de Craecker is an Independent Director at Gensight Biologics SA and X4 Pharmaceuticals, Inc. She is also the Senior Vice President & GM-European Operations at Horizon Pharmaceutical LLC.
Previously, she held positions as the Senior Vice President & General Manager at Raptor Pharmaceuticals Europe BV in 2017, the General Manager-Europe Middle East & Africa at Novartis Gene Therapies, Inc. from 2018 to 2019, and the Vice President & General Manager-Northern Europe at Transkaryotic Therapies, Inc. from 2000 to 2014.
Ms. de Craecker graduated from Katholieke Universiteit Leuven.
Current job(s): Independent Director at Gensight Biologics SA, Independent Director at X4 Pharmaceuticals, Inc., Senior Vice President & GM-European Operations at Horizon Pharmaceutical LLC.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
0,06% | 10/06/2024 | 96 667 ( 0,06% ) | 97 634 $ | 31/05/2024 |
Postes actifs de Françoise de Craecker
| Sociétés | Poste | Début |
|---|---|---|
| RAPTOR PHARMACEUTICAL CORP | Corporate Officer/Principal | 01/01/2014 |
| GENSIGHT BIOLOGICS S.A. | Directeur/Membre du Conseil | 16/05/2021 |
| X4 PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/10/2021 |
Anciens postes connus de Françoise de Craecker
| Sociétés | Poste | Fin |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 01/09/2019 |
Raptor Pharmaceuticals Europe BV
 Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., Raptor Pharmaceuticals Europe BV is a Dutch company that engages in research and experimental development in other physical and natural sciences. The company is based in Louveciennes, the Netherlands. | Corporate Officer/Principal | 01/12/2017 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | 01/03/2014 |
Formation de Françoise de Craecker
| Katholieke Universiteit Leuven | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Raptor Pharmaceuticals Europe BV
Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., Raptor Pharmaceuticals Europe BV is a Dutch company that engages in research and experimental development in other physical and natural sciences. The company is based in Louveciennes, the Netherlands. | Commercial Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
